The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods
Open accessAbstract
ChEMBL (https://www.ebi.ac.uk/chembl/) is a manually curated, high-quality, large-scale, open, FAIR and Global Core Biodata Resource of bioactive molecules with drug-like properties, previously described in the 2012, 2014, 2017 and 2019 Nucleic Acids Research Database Issues. Since its introduction in 2009, ChEMBL’s content has changed dramatically in size and diversity of data types. Through incorporation of multiple new datasets from depositors since the 2019 update, ChEMBL now contains slightly more bioactivity data from deposited data vs data extracted from literature. In collaboration with the EUbOPEN consortium, chemical probe data is now regularly deposited into ChEMBL. Release 27 made curated data available for compounds screened for potential anti-SARS-CoV-2 activity from several large-scale drug repurposing screens. In addition, new patent bioactivity data have been added to the latest ChEMBL releases, and various new features have been incorporated, including a Natural Product likeness score, updated flags for Natural Products, a new flag for Chemical Probes, and the initial annotation of the action type for ∼270 000 bioactivity measurements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Gilson, M. K., Liu, T., Baitaluk, M., Nicola, G., Hwang, L., & Chong, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1072 · Cited by 1,628
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Correa Marrero, M., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 1,020
Self-citationUltra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
The target landscape of clinical kinase drugs
Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P.-A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., et al. (2017) · Science · doi:10.1126/science.aan4368 · Cited by 854
An open source chemical structure curation pipeline using RDKit
Bento, A. P., Hersey, A., Félix, E., Landrum, G., Gaulton, A., Atkinson, F., Bellis, L. J., De Veij, M., & Leach, A. R. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00456-1 · Cited by 796
Self-citationCOCONUT online: Collection of Open Natural Products database
Sorokina, M., Merseburger, P., Rajan, K., Yirik, M. A., & Steinbeck, C. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-020-00478-9 · Cited by 665
Large-scale comparison of machine learning methods for drug target prediction on ChEMBL
Mayr, A., Klambauer, G., Unterthiner, T., Steijaert, M., Wegner, J. K., Ceulemans, H., Clevert, D.-A., & Hochreiter, S. (2018) · Chemical Science · doi:10.1039/c8sc00148k · Cited by 584
Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries
Ertl, P., Roggo, S., & Schuffenhauer, A. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700286x · Cited by 387
Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.14 · Cited by 378 · cited 1×
“We have focused on identifying patents with bioactivity data for small molecules against understudied targets, in collaboration with the Illuminating the Druggable Genome project ( 25 ).”
BackgroundSelf-citationDe Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
An overview of PROTACs: a promising drug discovery paradigm
Liu, Z., Hu, M., Yang, Y., Du, C., Zhou, H., Liu, C., Chen, Y., Fan, L., Ma, H., Gong, Y., et al. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00112-0 · Cited by 344
Erratum: Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.52 · Cited by 311
Self-citationSchneider, M., Radoux, C. J., Hercules, A., Ochoa, D., Dunham, I., Zalmas, L.-P., Hessler, G., Ruf, S., Shanmugasundaram, V., Hann, M. M., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00245-x · Cited by 273
Self-citationGaziano, L., Giambartolomei, C., Pereira, A. C., Gaulton, A., Posner, D. C., Swanson, S. A., Ho, Y.-L., Iyengar, S. K., Kosik, N. M., Vujkovic, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01310-z · Cited by 235
Self-citationSureChEMBL: a large-scale, chemically annotated patent document database
Papadatos, G., Davies, M., Dedman, N., Chambers, J., Gaulton, A., Siddle, J., Koks, R., Irvine, S. A., Pettersson, J., Goncharoff, N., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1253 · Cited by 229
Self-citationTarget-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies
Leeson, P. D., Bento, A. P., Gaulton, A., Hersey, A., Manners, E. J., Radoux, C. J., & Leach, A. R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00416 · Cited by 176
Self-citationActivity, assay and target data curation and quality in the ChEMBL database
Papadatos, G., Gaulton, A., Hersey, A., & Overington, J. P. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9860-5 · Cited by 168
Self-citationUniChem: a unified chemical structure cross-referencing and identifier tracking system
Chambers, J., Davies, M., Gaulton, A., Hersey, A., Velankar, S., Petryszak, R., Hastings, J., Bellis, L., McGlinchey, S., & Overington, J. P. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-3 · Cited by 165
Self-citationBosc, N., Atkinson, F., Felix, E., Gaulton, A., Hersey, A., & Leach, A. R. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-018-0325-4 · Cited by 165
Self-citationRasooly, D., Peloso, G. M., Pereira, A. C., Dashti, H., Giambartolomei, C., Wheeler, E., Aung, N., Ferolito, B. R., Pietzner, M., Farber‐Eger, E. H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39253-3 · Cited by 146
Self-citationOpen-source discovery of chemical leads for next-generation chemoprotective antimalarials
Antonova‐Koch, Y., Meister, S., Abraham, M., Luth, M. R., Ottilie, S., Lukens, A. K., Sakata, T., Vanaerschot, M., Owen, E. S., Jado, J. C., et al. (2018) · Science · doi:10.1126/science.aat9446 · Cited by 138
Designing optimized drug candidates with Generative Adversarial Network
Abbasi, M., Santos, B. P., Pereira, T. C., Sofia, R., Monteiro, N. R. C., Simões, C. J. V., Brito, R. M. M., Ribeiro, B., Oliveira, J. L., & Arrais, J. P. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00623-6 · Cited by 129
The ELIXIR Core Data Resources: fundamental infrastructure for the life sciences
Drysdale, R., Cook, C. E., Petryszak, R., Gerritsen, V. B., Barlow, M., Gasteiger, E., Gruhl, F., Haas, J., Lanfear, J., López, R., et al. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz959 · Cited by 88
Self-citationImputation of Assay Bioactivity Data Using Deep Learning
Whitehead, T. M., Irwin, B., Hunt, P. A., Segall, M., & Conduit, G. J. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00768 · Cited by 83
The Rise and Fall of a Scaffold: A Trend Analysis of Scaffolds in the Medicinal Chemistry Literature
Zdrazil, B., & Guha, R. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00954 · Cited by 62
Self-citationThe era of high-quality chemical probes
Licciardello, M. P., & Workman, P. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00291d · Cited by 62
Graphical representation of stereochemical configuration (IUPAC Recommendations 2006)
Brecher, J. (2006) · Pure and Applied Chemistry · doi:10.1351/pac200678101897 · Cited by 49
Abraham, M., Gagaring, K., Martino, M. L., Vanaerschot, M., Plouffe, D., Calla, J., Godinez‐Macias, K. P., Du, A. Y., Wree, M., Antonova‐Koch, Y., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00482 · Cited by 45
MAIP: a web service for predicting blood‐stage malaria inhibitors
Bosc, N., Félix, E., Arcila, R., Méndez, D., Saunders, M. R., Green, D. V. S., Ochoada, J., Shelat, A. A., Martin, É., Iyer, P., et al. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00487-2 · Cited by 45
Self-citationMoving targets in drug discovery
Zdrazil, B., Richter, L., Brown, N., & Guha, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-77033-x · Cited by 37
Self-citationPublic Resources for Chemical Probes: The Journey so Far and the Road Ahead
Antolín, A. A., Workman, P., & Al‐Lazikani, B. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0231 · Cited by 36
Development and Testing of Druglike Screening Libraries
Wang, J., Ge, Y., & Xie, X. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00537 · Cited by 34
Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs
Hunter, F. M. I., Bento, A. P., Bosc, N., Gaulton, A., Hersey, A., & Leach, A. R. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00296 · Cited by 28
Self-citationHanser, T., Steinmetz, F. P., Plante, J. P., Rippmann, F., & Krier, M. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0334-y · Cited by 22
Analysis of the benefits of imputation models over traditional QSAR models for toxicity prediction
Walter, M., Allen, L. N., de León, A. D. L. V., Webb, S. J., & Gillet, V. J. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00611-w · Cited by 21
Morger, A., de Lomana, M. G., Norinder, U., Svensson, F., Kirchmair, J., Mathea, M., & Volkamer, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-09309-3 · Cited by 19
Tuerkova, A., Ungvári, O., Laczkó-Rigó, R., Mernyák, E., Szakács, G., Özvegy‐Laczka, C., & Zdrazil, B. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00362 · Cited by 13
Self-citationIlluminating the druggable genome through patent bioactivity data
Magariños, M. P., Gaulton, A., Félix, E., Kizilören, T., Arcila, R., Oprea, T. I., & Leach, A. R. (2023) · PeerJ · doi:10.7717/peerj.15153 · Cited by 12
Self-citationA large-scale dataset of in vivo pharmacology assay results
Hunter, F. M. I., Atkinson, F. L., Bento, A. P., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.230 · Cited by 11
Self-citation
Cited by
Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction
Passaro, S., Corso, G., Wohlwend, J., Reveiz, M., Thaler, S., Somnath, V. R., Getz, N., Portnoi, T., Roy, J., Stark, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.14.659707 · Cited by 665
Network pharmacology: a crucial approach in traditional Chinese medicine research
Zhai, Y., Liu, L., Zhang, F., Chen, X., Wang, H., Zhou, J., Chai, K., Liu, J., Lei, H., Lu, P., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-024-01056-z · Cited by 260
Deep learning for low-data drug discovery: Hurdles and opportunities
van Tilborg, D., Brinkmann, H., Criscuolo, E., Rossen, L., Özçelik, R., & Grisoni, F. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102818 · Cited by 61
(2024) · doi:10.1038/s41467-024-52146-3 · Cited by 32
Attention-based approach to predict drug–target interactions across seven target superfamilies
Schulman, A., Rousu, J., Aittokallio, T., & Tanoli, Z. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae496 · Cited by 25
Metadata
- Authors
- Zdrazil, B., Felix, E., Hunter, F., Manners, E. J., Blackshaw, J., Corbett, S., de Veij, M., Ioannidis, H., Lopez, D. M., Mosquera, J. F., Magarinos, M. P., Bosc, N., Arcila, R., Kizilören, T., Gaulton, A., Bento, A. P., Adasme, M. F., Monecke, P., Landrum, G. A., & Leach, A. R.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-11-02
- Volume
- 52
- Issue
- D1
- Pages
- D1180-D1192
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W4388455891
- Cited by
- 1,413
- References
- 41
- FWCI
- 187.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.